Relationship between plasma resistin concentrations, inflammatory chemokines, and components of the metabolic syndrome in adults

被引:62
作者
Aquilante, Christina L. [1 ]
Kosmiski, Lisa A. [2 ]
Knutsen, Shannon D. [1 ]
Zineh, Issam [3 ,4 ]
机构
[1] Univ Colorado, Denever Sch Pharm, Dept Pharmaceut Sci, Denver, CO 80262 USA
[2] Univ Colorado, Sch Med, Div Endocrinol Diabet & Metab, Aurora, CO 80045 USA
[3] Univ Florida, Coll Pharm, Ctr Pharmacogenom, Gainesville, FL 32610 USA
[4] Univ Florida, Coll Pharm, Dept Pharm Practice, Gainesville, FL 32610 USA
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 2008年 / 57卷 / 04期
关键词
D O I
10.1016/j.metabol.2007.11.010
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Recent data suggest that resistin, an adipocyte-derived cytokine, has a putative role in inflammatory processes and metabolic derangements. in vitro data suggest that resistin stimulates the production of inflammatory chemokines, yet the relationship in vivo is largely unknown. The purpose of this study was to determine if a relationship exists between plasma resistin concentrations, plasma inflammatory chemokine aged concentrations (ie, monocyte chemoattractant protein 1 [MCP-1] and epithelial neutrophil activator 78 [ENA-78]), and components of the metabolic syndrome in nondiabetic subjects without known cardiovascular disease (CVD). Plasma samples were obtained from nondiabetic subjects (N = 123) aged 18 to 55 years without known CVD or CVD risk equivalents. The presence of the metabolic syndrome was assessed using consensus guidelines. Fasting plasma resistin, MCP-1, ENA-78, and high-sensitivity C-reactive protein (hs-CRP) concentrations were analyzed. The study population consisted of 67.5% women and 68.3% Caucasians (mean age = 44 7 years and mean body mass index = 33.3 +/- 6 kg/m(2)). The metabolic syndrome was present in 46.3% of study participants. Resistin concentrations were significantly correlated with white blood cell count (r = 0.326, P < .001), hs-CRP concentrations (r = 0.293, P = .005), MCP-1 concentrations (r = 0.251, P = .005), body mass index (r = 0.193, P = .033), and high-density lipoprotein cholesterol (r = -0.182, P = .044). Resistin concentrations were 1.21 times higher in subjects with the metabolic syndrome compared with those without the metabolic syndrome (P = .003). In stepwise regression analysis, white blood cell count (P < .001) and MCP-1 concentrations (P = .002) were significantly associated with resistin concentrations, independent of hs-CRP, sex, body mass index, presence of the metabolic syndrome, and high-density lipoprotein cholesterol. Data from our cross-sectional study demonstrate that plasma resistin concentrations are associated with circulating chemokine markers of inflammation, namely, MCP-1, and white blood cell count in nondiabetic adults without CVD. Future studies examining the causal relationship between plasma resistin concentrations, chemokine markers of inflammation, CVD, and diabetes are warranted. (c) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:494 / 501
页数:8
相关论文
共 31 条
[1]
Serum resistin is associated with C-reactive protein and LDL- cholesterol in type 2 diabetes and coronary artery disease in a Saudi population [J].
Al-Daghri, N. ;
Chetty, R. ;
McTernan, P. G. ;
Al-Rubean, K. ;
Al-Attas, O. ;
Jones, A. F. ;
Kumar, S. .
CARDIOVASCULAR DIABETOLOGY, 2005, 4 (1)
[2]
Relationships between human serum resistin, inflammatory markers and insulin resistance [J].
Bo, S ;
Gambino, R ;
Pagani, A ;
Guidi, S ;
Gentile, L ;
Cassader, M ;
Pagano, GF .
INTERNATIONAL JOURNAL OF OBESITY, 2005, 29 (11) :1315-1320
[3]
Resistin, an adipokine with potent proinflammatory properties [J].
Bokarewa, M ;
Nagaev, I ;
Dahlberg, L ;
Smith, U ;
Tarkowski, A .
JOURNAL OF IMMUNOLOGY, 2005, 174 (09) :5789-5795
[4]
The specific role of chemokines in atherosclerosis [J].
Braunersreuther, Vincent ;
Mach, Francois ;
Steffens, Sabine .
THROMBOSIS AND HAEMOSTASIS, 2007, 97 (05) :714-721
[5]
The potential role of resistin in atherogenesis [J].
Burnett, MS ;
Lee, CW ;
Kinnaird, TD ;
Stabile, E ;
Durrani, S ;
Dullum, MK ;
Devaney, JM ;
Fishman, C ;
Stamou, S ;
Canos, D ;
Zbinden, S ;
Clavijo, LC ;
Jang, GJ ;
Andrews, JA ;
Zhu, JH ;
Epstein, SE .
ATHEROSCLEROSIS, 2005, 182 (02) :241-248
[6]
Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes [J].
de Lemos, JA ;
Morrow, DA ;
Sabatine, MS ;
Murphy, SA ;
Gibson, CM ;
Antman, EM ;
McCabe, CH ;
Cannon, CP ;
Braunwald, E .
CIRCULATION, 2003, 107 (05) :690-695
[7]
Proinflammatory cytokine production and insulin sensitivity regulated by overexpression of resistin in 3T3-L1 adipocytes [J].
Fu, Yuchang ;
Luo, Liehong ;
Luo, Nanlan ;
Garvey, W. Timothy .
NUTRITION & METABOLISM, 2006, 3 (1)
[8]
Circulating mononuclear cells in the obese are in a proinflammatory state [J].
Ghanim, H ;
Aljada, A ;
Hofmeyer, D ;
Syed, T ;
Mohanty, P ;
Dandona, P .
CIRCULATION, 2004, 110 (12) :1564-1571
[9]
Low-dose rosiglitazone exerts an antiinflammatory effect with an increase in adiponectin independently of free fatty acid fall and insulin sensitization in obese type 2 diabetics [J].
Ghanim, Husam ;
Dhindsa, Sandeep ;
Aljada, Ahmad ;
Chaudhuri, Ajay ;
Viswanathan, Prabhakar ;
Dandona, Paresh .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (09) :3553-3558
[10]
Diagnosis and management of the metabolic syndrome - An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement [J].
Grundy, SM ;
Cleeman, JI ;
Daniels, SR ;
Donato, KA ;
Eckel, RH ;
Franklin, BA ;
Gordon, DJ ;
Krauss, RM ;
Savage, PJ ;
Smith, SC ;
Spertus, JA ;
Costa, F .
CIRCULATION, 2005, 112 (17) :2735-2752